alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Featured Grant OpportunitySchool Emergency Response to Violence (Project SERV) (Funding Opportunity) 

Featured Grant OpportunityShare with Youth: NOAA Student Opportunities Database

Featured Grant OpportunityShort Courses in Social Determinants of Health for Research Education in Nursing Research (Funding...

Featured Grant OpportunityComprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program (Funding Opportunity)

Featured Grant OpportunityRisk and Protective Factors of Family Health and Family Level Interventions (Funding Opportunity)

Featured Grant OpportunityPersonnel Development to Improve Services and Results for Children with Disabilities--Doctoral...

Featured Grant OpportunityStanding Announcement for Tribal Title IV-E Plan Development Grants (Funding Opportunity)

Featured Grant OpportunityProviding Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and...

Featured Grant OpportunityFY 2024 Research on School-Based Hate Crimes (Funding Opportunity)

Featured Grant OpportunityChallenge America (Funding Opportunity)

Featured Grant OpportunityResearch and Evaluation on Firearm Violence and Mass Shootings (Funding Opportunity)

Featured Grant OpportunityNational Juvenile Court Data Archive (Funding Opportunity)

Featured Grant OpportunityGraduate Research Fellowship (Funding Opportunity)

Featured Grant OpportunityCommunity Programs for Outreach and Intervention with Youth and Young Adults at Clinical High Risk...

Featured Grant OpportunityPrint and Disseminate Child Victims and Witnesses Support Materials (Funding Opportunity)

## Breadcrumb

            -  Evidence and Innovation 
            -  Teen Pregnancy Prevention Evidence Review 
            -           PPRER014967      

# PPRER014967

In-iw, S., Braverman, P. K., Bates, J. R.,  Biro, F. M. (2015). The impact of health education counseling on rate of recurrent sexually transmitted infections in adolescents. Journal of Pediatric  Adolescent Gynecology, 28(6), 481-485. doi:10.1016/j.jpag.2015.02.001

ModerateQuasi-experimental study that met all criteria for a moderate rating; findings show no positive, statistically significant impact on a relevant behavioral outcome measure for either the full sample or key subgroups

### Program Information

### Evaluation Setting

### Study Sample

### Research Design
<TABLE> <S> <C>


        <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
BALANCE SHEET, THE STATEMENT OF OPERATIONS, AND THE STATEMENT OF CASH FLOWS
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1

<S>                             <C>
<PERIOD-TYPE>                   OTHER
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             NOV-16-1999
<PERIOD-END>                               DEC-31-2000
<CASH>                                           8,510
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 8,510
<PP&E>                                          23,222
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  31,843
<CURRENT-LIABILITIES>                              645
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         2,940
<OTHER-SE>                                      28,903
<TOTAL-LIABILITY-AND-EQUITY>                    31,843
<SALES>                                              0
<TOTAL-REVENUES>                                 5,216
<CGS>                                                0
<TOTAL-COSTS>                                   32,468
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (27,252)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (27,252)
<EPS-BASIC>                                    (0.01)
<EPS-DILUTED>                                    (0.01)



</TABLE>
EXHIBIT 32


                    Certification of CEO and CFO Pursuant to
                             18 U.S.C. Section 1350,
                             As Adopted Pursuant to
                  Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report on Form 10-KSB of SLS International, Inc.
(the "Company") for the year ended December 31, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), John Gott,
Chief Executive Officer and Chief Financial Officer of the Company, hereby
certifies, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

     (1)    The Report fully complies with the requirements of Section 13(a)
            or 15(d) of the Securities Exchange Act of 1934; and

     (2)    The information contained in the Report fairly presents, in all
            material respects, the financial condition and results of operations
            of the Company.



/s/ John Gott
John Gott
Chief Executive Officer and Chief Financial Officer
March 28, 2005


This certification accompanies the Report pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of ss.
18 of the Securities Exchange Act of 1934, as amended.
# C_2020315EN.01000201.xml

| 23.9.2020 | EN | Official Journal of the European Union | C 315/2 |
| --- | --- | --- | --- |

23.9.2020

EN

Official Journal of the European Union

C 315/2

---

Euro exchange rates (1)

22 September 2020

(2020/C 315/02)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1740 |
| JPY | Japanese yen | 122,78 |
| DKK | Danish krone | 7,4417 |
| GBP | Pound sterling | 0,91743 |
| SEK | Swedish krona | 10,4070 |
| CHF | Swiss franc | 1,0748 |
| ISK | Iceland króna | 162,00 |
| NOK | Norwegian krone | 10,9528 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 27,007 |
| HUF | Hungarian forint | 362,05 |
| PLN | Polish zloty | 4,4934 |
| RON | Romanian leu | 4,8613 |
| TRY | Turkish lira | 8,9850 |
| AUD | Australian dollar | 1,6288 |
| CAD | Canadian dollar | 1,5631 |
| HKD | Hong Kong dollar | 9,0986 |
| NZD | New Zealand dollar | 1,7630 |
| SGD | Singapore dollar | 1,5998 |
| KRW | South Korean won | 1 363,87 |
| ZAR | South African rand | 19,5779 |
| CNY | Chinese yuan renminbi | 7,9550 |
| HRK | Croatian kuna | 7,5443 |
| IDR | Indonesian rupiah | 17 357,59 |
| MYR | Malaysian ringgit | 4,8539 |
| PHP | Philippine peso | 56,898 |
| RUB | Russian rouble | 89,1500 |
| THB | Thai baht | 36,840 |
| BRL | Brazilian real | 6,3677 |
| MXN | Mexican peso | 25,1194 |
| INR | Indian rupee | 86,2620 |

Currency

Exchange rate

USD

US dollar

1,1740

JPY

Japanese yen

122,78

DKK

Danish krone

7,4417

GBP

Pound sterling

0,91743

SEK

Swedish krona

10,4070

CHF

Swiss franc

1,0748

ISK

Iceland króna

162,00

NOK

Norwegian krone

10,9528

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

27,007

HUF

Hungarian forint

362,05

PLN

Polish zloty

4,4934

RON

Romanian leu

4,8613

TRY

Turkish lira

8,9850

AUD

Australian dollar

1,6288

CAD

Canadian dollar

1,5631

HKD

Hong Kong dollar

9,0986

NZD

New Zealand dollar

1,7630

SGD

Singapore dollar

1,5998

KRW

South Korean won

1 363,87

ZAR

South African rand

19,5779

CNY

Chinese yuan renminbi

7,9550

HRK

Croatian kuna

7,5443

IDR

Indonesian rupiah

17 357,59

MYR

Malaysian ringgit

4,8539

PHP

Philippine peso

56,898

RUB

Russian rouble

89,1500

THB

Thai baht

36,840

BRL

Brazilian real

6,3677

MXN

Mexican peso

25,1194

INR

Indian rupee

86,2620

---

(1)  Source: reference exchange rate published by the ECB.

---
#### Steve Zgliczynski, appellee, v. Ludwig Sokol and Frances Sokol, appellants.

Gen. No. 30,561.

Action for work and material furnished pursuant to contract. Judgment for plaintiff. Appeal from the Municipal Court of Chicago; the Hon. Alfar M. Eberhardt, Judge, presiding. Heard in the second division of this court for the first district at the October term, 1925.

Affirmed.

Opinion filed May 25, 1926.

Rehearing denied June 7, 1926.

Frank N. Hillis, for appellants.

Olithero, Van Sehaiek & Stevens, for appellee; Guy Van Sehaiek, of counsel.

Mr. Justice Fitch

delivered the opinion of the court.
Featured Grant OpportunitySchool Emergency Response to Violence (Project SERV) (Funding Opportunity) 

Featured Grant OpportunityShare with Youth: NOAA Student Opportunities Database

Featured Grant OpportunityShort Courses in Social Determinants of Health for Research Education in Nursing Research (Funding...

Featured Grant OpportunityComprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program (Funding Opportunity)

Featured Grant OpportunityRisk and Protective Factors of Family Health and Family Level Interventions (Funding Opportunity)

Featured Grant OpportunityPersonnel Development to Improve Services and Results for Children with Disabilities--Doctoral...

Featured Grant OpportunityStanding Announcement for Tribal Title IV-E Plan Development Grants (Funding Opportunity)

Featured Grant OpportunityProviding Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and...

Featured Grant OpportunityFY 2024 Research on School-Based Hate Crimes (Funding Opportunity)

Featured Grant OpportunityChallenge America (Funding Opportunity)

Featured Grant OpportunityResearch and Evaluation on Firearm Violence and Mass Shootings (Funding Opportunity)

Featured Grant OpportunityNational Juvenile Court Data Archive (Funding Opportunity)

Featured Grant OpportunityGraduate Research Fellowship (Funding Opportunity)

Featured Grant OpportunityCommunity Programs for Outreach and Intervention with Youth and Young Adults at Clinical High Risk...

Featured Grant OpportunityPrint and Disseminate Child Victims and Witnesses Support Materials (Funding Opportunity)

## Breadcrumb

            -           Maternal, Infant, and Early Childhood Home Visiting      

# Maternal, Infant, and Early Childhood Home Visiting

U.S. Department of Health and Human Services, Health Resources and Service Administration

This webpage provides information about the Maternal, Infant, and Early Childhood Home Visiting (MIECHV) programs that aim to improve maternal and child health, prevent child abuse and neglect, encourage positive parenting, and promote child development and school readiness. It includes links to information about grants and grantees, home visiting models, and technical assistance.

Behavioral health (mental health and substance abuse)

Early childhood development

Federal programs

Health care

Homeless: families

Housing

Service providers

Webpage

http://mchb.hrsa.gov/programs/homevisiting/index.html
[Federal Register Volume 86, Number 32 (Friday, February 19, 2021)]
[Notices]
[Page 10359]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03389]


=======================================================================
-----------------------------------------------------------------------

NATIONAL SCIENCE FOUNDATION


Advisory Committee for International Science and Engineering; 
Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 
92-463, as amended), the National Science Foundation (NSF) announces 
the following meeting:

    Name and Committee Code: Advisory Committee for International 
Science and Engineering Meeting (AC-ISE) (#25104).
    Date and Time: Friday, March 19, 2021, 10:00 a.m. to 5:00 p.m. 
(Eastern Time).
    Place: NSF, 2415 Eisenhower Avenue, Alexandria, VA 22314 [verbar] 
Virtual Zoom.
    This AC-ISE meeting is fully virtual. All public participants are 
required to process the meeting registration via Zoom.
    Connect to The Virtual Meeting: Register in advance for the meeting 
at the Zoom attendee registration link: https://nsf.zoomgov.com/webinar/register/WN_IRrGAhXcRO2DvpdH7jAVjA. After registering, you will 
receive a confirmation email with a unique link to join the meeting.
    If you have any login questions, please contact Kirk Grabowski, 
OISE IT Specialist: <a href="/cdn-cgi/l/email-protection#d6bdb1a4b7b4b9a1a596b7a5a5b9b5bfb7a2b3a5f8b8a5b0f8b1b9a0"><span class="__cf_email__" data-cfemail="c4afa3b6a5a6abb3b784a5b7b7aba7ada5b0a1b7eaaab7a2eaa3abb2">[email protected]</span></a>.
    Type of Meeting: Open.
    Contact Person: Christopher Street, National Science Foundation, 
2415 Eisenhower Avenue, Room W-17220, Alexandria, Virginia 22314; 
Telephone: (703) 292-8568/Email: <a href="/cdn-cgi/l/email-protection#fe9d8d8a8c9b9b8abe908d98d0999188"><span class="__cf_email__" data-cfemail="2340505751464657634d50450d444c55">[email protected]</span></a>.
    Purpose of Meeting: To provide advice, recommendations and counsel 
on major goals and policies pertaining to international programs and 
activities.

Agenda

<bullet> Updates on OISE activities
<bullet> Discussion on Global Leadership in Science, Engineering, and 
Education
<bullet> Innovative Partnerships
<bullet> Meet with NSF leadership

    Dated: February 16, 2021.
Crystal Robinson,
Committee Management Officer.
[FR Doc. 2021-03389 Filed 2-18-21; 8:45 am]
BILLING CODE 7555-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
#### 722.103-1 Definitions.

*Compensatory time off* means leave equal to overtime worked, which, unless otherwise authorized in a contract or approved by a contracting officer, must be taken not later than the end of the calendar month following that in which the overtime is worked.
Exhibit 10.6


 


THIRD AMENDMENT TO SUPPLY AGREEMENT


 


This THIRD AMENDMENT TO SUPPLY AGREEMENT (this "Amendment') is entered into as of the 30TH day of April, 2011 (the "Amendment Effective Date"), by and between Uroplasty, Inc. ("Purchaser"), and Tyco Healthcare Group LP (d/b/a Covidien) acting through its Uni-Patch Division ("Supplier).


 


Supplier and Purchaser are both parties to a Supply Agreement, dated December 6th, 2007, which was amended by the First Amendment to Supply Agreement, dated February 26th, 2008 and the Second Amendment to Supply Agreement, dated March 24, 2010 (the "Agreement'). The parties wish to amend the Agreement in accordance with the terms and conditions set forth herein. Any capitalized term used in this Amendment without definition will have the meaning ascribed to it in the Agreement.


 


NOW, THEREFORE, the parties hereto agree as follows:


 


Section 1.          Contract Year. Section 1.1 of the Agreement is hereby deleted and replaced with the following:


 


1.1          "Contract Year shall mean each consecutive twelve-month period commencing as of May 1 and ending as of the immediately succeeding April 30.


 


Section 2.          Term. Section 2 of the Supply Agreement is hereby deleted and replaced with the following:


 


This Agreement shall commence upon the Effective Date and shall continue in effect until April 30, 2014 ("Term"), unless earlier terminated pursuant to Section 8.


 


Section 3.          Products and Pricing. Exhibit A of the Agreement is hereby amended by deleting it in its entirety and replacing it with the Exhibit A attached to this Amendment.


 


Section 4.          Ratification. Except as specifically provided in this Amendment, the terms and provisions of the Agreement will be and remain unaltered and in full force and effect. For avoidance of doubt, the parties expressly agree and confirm that the Agreement has continued, and does continue, in full force and effect and without lapse or termination notwithstanding whether the actual date of execution hereof is after the Amendment Effective Date.


 


THE PARTIES HAVE CAUSED this Amendment to be duly executed as of the Amendment Effective Date.


 


	
UROPLASTY, INC.

	
TYCO HEALTHCARE GROUP LP (D/B/A


COVIDIEN acting through its Uni-Patch Division





 



	
By:

	
/s/ Tony Mulone

	
By:

	
/s/ Marc M. Herregraven


	
Name:  

	
Tony Mulone

	
Name:  

	
Marc M. Herregraven


	
Title:

	
VP/GM – OEM Division

	
Title:

	
VP of Manufacturing







 











EXHIBIT A


Products and Pricing


 



	 	
Product Code

	 	
Description

	 	
Price


	 	
UPC250-12

	 	
UPC Stimulation Lead Sets

	 	
$*







 


Lead Time for Shipments from Date of Purchase Order: 8 weeks


 


Delivery Location: Minnetonka, MN








		*	
Indicates that confidential information has been omitted and filed separately with the Securities and Exchange Commission.
Featured Grant OpportunitySchool Emergency Response to Violence (Project SERV) (Funding Opportunity) 

Featured Grant OpportunityShare with Youth: NOAA Student Opportunities Database

Featured Grant OpportunityShort Courses in Social Determinants of Health for Research Education in Nursing Research (Funding...

Featured Grant OpportunityResearch on Law Enforcement Responses to Opioid Overdoses (Funding Opportunity)

Featured Grant OpportunityComprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program (Funding Opportunity)

Featured Grant OpportunityRisk and Protective Factors of Family Health and Family Level Interventions (Funding Opportunity)

Featured Grant OpportunityPersonnel Development to Improve Services and Results for Children with Disabilities--Doctoral...

Featured Grant OpportunityStanding Announcement for Tribal Title IV-E Plan Development Grants (Funding Opportunity)

Featured Grant OpportunityProviding Research Education Experiences to Enhance Inclusivity for a Diverse Substance Use and...

Featured Grant OpportunityFY 2024 Research on School-Based Hate Crimes (Funding Opportunity)

Featured Grant OpportunityChallenge America (Funding Opportunity)

Featured Grant OpportunityResearch and Evaluation on Firearm Violence and Mass Shootings (Funding Opportunity)

Featured Grant OpportunityNational Juvenile Court Data Archive (Funding Opportunity)

Featured Grant OpportunityGraduate Research Fellowship (Funding Opportunity)

Featured Grant OpportunityCommunity Programs for Outreach and Intervention with Youth and Young Adults at Clinical High Risk...

Featured Grant OpportunityPrint and Disseminate Child Victims and Witnesses Support Materials (Funding Opportunity)

## Breadcrumb

            -  Announcements 
            -           Resource: Youths with Intellectual and Developmental Disabilities in the Juvenile Justice System      

# Resource: Youths with Intellectual and Developmental Disabilities in the Juvenile Justice System

This literature review (PDF, 10 pages) summarizes research on intellectual and developmental disabilities of youths who are at risk of or who have come into contact with the juvenile justice system. Professionals working in juvenile justice settings can use this resource to better understand the challenges facing young people. Policymakers can also use the review to inform federal policies that pertain to the treatment of youths with disabilities in the juvenile justice system. **Learn more** (PDF, 10 pages).
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               MAR-30-1997
<CASH>                                          28,657
<SECURITIES>                                         0
<RECEIVABLES>                                   35,636
<ALLOWANCES>                                       857
<INVENTORY>                                     55,354
<CURRENT-ASSETS>                               139,000
<PP&E>                                          74,345
<DEPRECIATION>                                  34,242
<TOTAL-ASSETS>                                 291,909
<CURRENT-LIABILITIES>                           49,734
<BONDS>                                        124,202
<PREFERRED-MANDATORY>                            4,156
<PREFERRED>                                          0
<COMMON>                                           187
<OTHER-SE>                                     101,787
<TOTAL-LIABILITY-AND-EQUITY>                   291,909
<SALES>                                         53,888
<TOTAL-REVENUES>                                53,888
<CGS>                                           36,870
<TOTAL-COSTS>                                   52,064
<OTHER-EXPENSES>                                   909
<LOSS-PROVISION>                                   153
<INTEREST-EXPENSE>                               3,135
<INCOME-PRETAX>                                (1,950)
<INCOME-TAX>                                     (942)
<INCOME-CONTINUING>                            (1,008)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,008)
<EPS-PRIMARY>                                    (.05)
<EPS-DILUTED>                                    (.05)
        

</TABLE>